US FDA’s Standard Application Assessment Makes A Comeback
Executive Summary
After years where many more applications received priority assessments than standard assessments, in FY 2022 the difference narrowed.
You may also be interested in...
ARPA-H, US FDA Discuss Incentives For Game-Changing Health Projects
Because the Advanced Research Projects Agency for Health can reimburse FDA for services, the two agencies are discussing what that could be available, such as priority assessments, when the projects reach the application stage.
Preparing For A Shutdown: US FDA To Retain 81% Of Workforce, Thanks Mostly To User Fees
However, user fee carryover balances will not last forever and service cuts are inevitable if a shutdown lingers for several weeks.
Republican Lawmaker Takes Unusual Step Of Attacking FDA Salaries Over Abortion Pill Decisions
A move to cut senior FDA positions including CDER Director through the appropriations process is rare and almost certain to fail, but experts say the attempt is indicative of an environment that seems to be encouraging these personal amendments.